BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21781143)

  • 1. Plasma corticotrophin response to desmopressin in patients with Cushing's disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours.
    Wang FF; Tang KT; Yen YS; Ho DM; Yang AH; Huang CI; Lin HD; Won JG
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):253-63. PubMed ID: 21781143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
    Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
    Dahia PL; Ahmed-Shuaib A; Jacobs RA; Chew SL; Honegger J; Fahlbusch R; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1996 May; 81(5):1768-71. PubMed ID: 8626831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications.
    Luque RM; Ibáñez-Costa A; López-Sánchez LM; Jiménez-Reina L; Venegas-Moreno E; Gálvez MA; Villa-Osaba A; Madrazo-Atutxa AM; Japón MA; de la Riva A; Cano DA; Benito-López P; Soto-Moreno A; Gahete MD; Leal-Cerro A; Castaño JP
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4160-9. PubMed ID: 23884782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
    Pecori Giraldi F; Marini E; Torchiana E; Mortini P; Dubini A; Cavagnini F
    J Endocrinol; 2003 Jun; 177(3):373-9. PubMed ID: 12773117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing's syndrome.
    Machado MC; de Sa SV; Domenice S; Fragoso MC; Puglia P; Pereira MA; de Mendonça BB; Salgado LR
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):136-42. PubMed ID: 17201813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor.
    Sekiguchi Y; Miyamoto Y; Kasahara I; Hara Y; Tani Y; Doi M; Hirata Y
    Endocr J; 2015; 62(5):441-7. PubMed ID: 25819222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro.
    Arlt W; Dahia PL; Callies F; Nordmeyer JP; Allolio B; Grossman AB; Reincke M
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):623-7. PubMed ID: 9425403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The desmopressin test in the diagnosis of Cushing's disease].
    Gasińiska T; Dec R; Wichary H; Pietrasik L; Kulawik G
    Pol Arch Med Wewn; 2007; 117(1-2):20-6. PubMed ID: 17642202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
    Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
    J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH and cortisol responses to ghrelin and desmopressin in patients with Cushing's disease and adrenal enlargement.
    Miljic D; Joksimovic M; Doknic M; Ivovic M; Djurovic M; Pekic S; Tancic M; Soldatovic I; Stojanovic M; Nale Dj; Macut Dj; Damjanovic S; Popovic V
    J Endocrinol Invest; 2010 Sep; 33(8):526-9. PubMed ID: 20142632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.
    Dall'Asta C; Barbetta L; Bonavina L; Beck-Peccoz P; Ambrosi B
    Pituitary; 2004; 7(3):183-188. PubMed ID: 16328567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.